🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and effectiveness of...
Status
Terminated
Location
Orange County Research Center
Start Date
2013-12
Trial ID
NCT02020616
Treatments Being Tested
Type 2 diabetes mellitus is a chronic metabolic disorder characterized by p...
Status
Completed
Location
Mount Sinai Hospital
Start Date
2014-09
Trial ID
NCT02194595
Treatments Being Tested
A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Exami...
Status
Completed
Location
Research Site 182
Start Date
2006-04
Trial ID
NCT00308139
Treatments Being Tested
The purpose of this investigation is to evaluate whether exenatide, a type ...
Status
Completed
Location
Phoenix VA Medical Center
Start Date
2010-08
Trial ID
NCT01181986
Treatments Being Tested
Background: Exendin-4 (or Exenatide) is a medication currently used to tre...
Status
Terminated
Location
National Institute on Aging, Clinical Research Unit
Start Date
2010-11-21
Trial ID
NCT01255163
Treatments Being Tested
The glucagon-like peptide 1 (GLP-1) agonist exenatide represents an effecti...
Status
Completed
Location
University Hospital of Palermo
Start Date
2015-01
Trial ID
NCT02380521
Treatments Being Tested
The main purpose of this study is to compare the safety and effectiveness o...
Status
Completed
Location
John Muir Physician Network Clinical Research Center
Start Date
2014-04
Trial ID
NCT02119819
Treatments Being Tested
The purpose of this study is to determine if exenatide improves end-of-trea...
Status
Completed
Location
Michael E. DeBakey VA Medical Center
Start Date
2022-12-07
Trial ID
NCT05610800
Treatments Being Tested
Idiopathic intracranial hypertension (IIH) has significant associated morbi...
Status
Terminated
Location
UCHealth Sue Anschutz-Rodgers Eye Center - Anschutz Medical Campus
Start Date
2022-11-18
Trial ID
NCT05347147